Now Enrolling

patients that are at high risk for sudden cardiac
arrest upon discharge from recent cardiac
hospitalization for the Jewel IDE Study.

Now Enrolling

patients that are at high risk for sudden cardiac arrest upon discharge from recent cardiac hospitalization for the Jewel IDE Study.

The Jewel IDE Study

A Clinical Evaluation of the Jewel Patch Cardioverter Defibrillator (P-WCD) in subjects at high risk for sudden cardiac arrest. To demonstrate the safety and clinical effectiveness of the Jewel P-WCD.

Providers

Now recruiting for a national study at selected sites across the US, primarily in the southern, midwest, and northeast states.

Patients

The Jewel detects specific life-threatening heart rhythms and delivers an electrical shock to restore normal heart activity.

This product is not currently available for sale in the U.S.